Answers are grounded in this paper and cite their sources.
Metformin, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) and sodium glucose cotransport 2 inhibitors (SGLT2i) are the most frequently prescribed medications for the treatment of diabetes. While the efficacy of these anti-diabetic drugs is clear, the underlying mechanisms of how they improve metabolism and produce other seemingly beneficial off-target effects are not clear. Several tissues including skeletal muscle have been implicated in the on-target and off-target actions of these drugs. Satellite cells are muscle stem cells that are important for skeletal muscle adaptation to stimuli such as exercise. In this mini-review, we present the emerging evidence exploring whether Metformin, GLP-1RA, SGLT2i modulate satellite cell function and if this is a relevant therapeutic target.
No takes yet. Share an insight, caveat, or question.
Skiles et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: